Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-28T18:33:03.377Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical trials in psychiatry1

Published online by Cambridge University Press:  09 July 2009

Anthony L. Johnson
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Psychological Medicine , Volume 13 , Issue 1 , February 1983 , pp. 1 - 8
Copyright
Copyright © Cambridge University Press 1983

References

Altman, D. G. (1980). Statistics and ethics in medical research. Misuse of Statistics 15 unethical. British Medical Journal ii, 1182–1184.CrossRefGoogle Scholar
Barker, N., Hews, R. J., Huitson, A. & Poloniecki, J. (1982). The two period cross over trial. Bulletin in Applied Statistics 9, 67–116.CrossRefGoogle Scholar
British Medical Journal (1977). Leading article: Adverse effects of lithium treatment; ii, 346–347.Google Scholar
British Medical Journal (1978). Leading article: Interpreting clinical trials; ii, 1318.Google Scholar
Bull, J. P. (1959). The historical development of clinical therapeutic trials. Journal of Chronic Disease 10, 218–248.CrossRefGoogle ScholarPubMed
Chalmers, T. C., Smith, H., Blackburn, B., Silvermann, B., Schroeder, B., Rettman, D. & Ambroz, A. (1981). A method of assessing the quality of a randomized clinical trial. Controlled Clinical Trials 2. 31–49.CrossRefGoogle Scholar
Chaput de tonge, D. M. (1977). Aide-memoire for preparing clinical trial protocols. British Medical Journal i, 1323–1324.Google Scholar
Cohen, J. (1977). Statistical Power Analysis for the Behavioural Sciences (second edn). Academic Press: New York and London.Google Scholar
Controlled Clinical Trials. Design and Methods (1980). Official Journal of the Society for Clinical Trials. Elsevier/North Holland: Amsterdam.Google Scholar
Drug Trials in General Practice (1981). Drug and Therapeutics Bulletin 19, 97–99.CrossRefGoogle Scholar
Freedman, L. S. (1982). Tables of the number of patients required in clinical trials using the logrank test. Statistics in Medicine 1, 121–129.CrossRefGoogle ScholarPubMed
Freiman, J. A., Chalmers, T. C., Smith, H. & Kuebler, R. R. (1978). The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 ‘negative’ trials. New England Journal of Medicine 299, 690–694.CrossRefGoogle ScholarPubMed
Friedman, L. M., Furberg, C. D. & DeMets, D. L. (1981). Fundamentals of Clinical Trials. John Wright: Bristol.Google Scholar
Godwin-Austen, R. B., Frears, C. C., Bergmann, S., Parkes, J. D. & Knill-Jones, R. P. (1970). Combined treatment of Parkinsonism with L-dopa and amantadine. Lancet ii, 383–385.CrossRefGoogle Scholar
Gore, S. M. (1981 a). Assessing clinical trials-rash adventures. British Medical Journal ii, 426–428.CrossRefGoogle Scholar
Gore, S. M. (1981 b). Assessing methods-confidence intervals. British Medical Journal ii, 660–662.CrossRefGoogle Scholar
Gore, S. M. (1982). Statistics in question: assessing clinical trials. In Statistics in Practice (by S. M. Gore and D. G. Altman). pp. 27–63. British Medical Association: London.Google Scholar
Grizzle, J. E. (1965). The two-period change-over design and its use in clinical trials. Biometrics 21, 467–480.CrossRefGoogle ScholarPubMed
Harris, E. L. & Fitzgerald, J. D. (eds.) (1970). The Principles and Practice of Clinical Trials. Livingstone: Edinburgh and London.Google Scholar
Hills, M. & Armitage, p. (1979). The two-period crossover clinical trial. British Journal of Clinical Pharmacology 8, 7–20.CrossRefGoogle Scholar
Hughes, R. C., Polgar, J. G., Weightman, D. & Walton, J. N. (1971). l-Dopa in Parkinsonism and the influence of previous thalamotomy. British Medical Journal i, 7–13.CrossRefGoogle Scholar
Johnson, F. N. & Johnson, S. (eds.) (1977). Clinical Trials. Blackwell: Oxford.Google Scholar
Johnstone, E. C., Deakin, J. F. W., Lawler, P., Frith, C. D., Stevens, M., McPherson, K. & Crow, T. J. (1980). The Northwick Park Electroconvulsive Therapy Trial. Lancet ii, 1317–1320.CrossRefGoogle Scholar
Lachin, J. M. (1981). Introduction to sample size determination and power analysis for clinical trials. Controlled Clinical Trials 2, 93–113.CrossRefGoogle ScholarPubMed
Lancet (1981). Leading article: Multicentre depression; ii, 563–564.Google Scholar
Mackay, A. V. P., Sheppard, G. P., Saha, B. K., Motley, B., Johnson, A. L. & Marsden, C. D. (1980). Failure of lithium treatment in established tardive dyskinesia. Psychological Medicine 10, 583–587.CrossRefGoogle ScholarPubMed
Medical Research Council (1962). A report by the Tuberculosis Chemotherapy Trials Committee. Long term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation. Tubercle 43, 201–267.CrossRefGoogle Scholar
Medical Research Council Drug Trials Subcommittee (1981). Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a controlled clinical trial. Psychological Medicine 11, 409–416.CrossRefGoogle Scholar
Paykel, E. S., DiMascio, A., Haskell, D. & Prusoff, B. A. (1975). Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine 5, 67–77.CrossRefGoogle ScholarPubMed
Peterson, A. V. & Fisher, L. D. (1980). Teaching the principles of clinical trials design and management. Biometrics 36, 687–697.CrossRefGoogle Scholar
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J. & Smith, P. G. (1976). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. British Journal of Cancer 34, 585–612.CrossRefGoogle ScholarPubMed
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J. & Smith, P. G. (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer 35, 1–39.CrossRefGoogle ScholarPubMed
Pocock, S. J. (1978). Size of cancer clinical trials and stopping rules. British Journal of Cancer 38, 757–766.CrossRefGoogle ScholarPubMed
Poloniecki, J. & Daniel, D. (1981). Further analysis of the Hills and Armitage data. The Statistician 30, 225–229.CrossRefGoogle Scholar
Porter, A. M. W. (1970). Depressive illness in a general practice. A demographic study and a controlled trial of imipramine. British Medical Journal i, 773–778.CrossRefGoogle Scholar
Schwartz, D., Flamant, R. & Lellouch, J. (1980). Clinical Trials (transl. Healy, M. J. R.). Academic Press: London.Google Scholar
Tate, H. C., Rawlinson, J. B. & Freedman, L. S. (1979). Randomized comparative studies in the treatment of cancer in the United Kingdom: room for improvement. Lancet ii, 623–625.CrossRefGoogle Scholar
Wallenstein, S. & Fisher, A. C. (1977). The analysis of the two-period repeated measurements crossover design with application to clinical trials. Biometrics 33, 261–269.CrossRefGoogle ScholarPubMed
Williams, P., Murray, J. & Clare, A. (1982). A longitudinal study of psychotropic drug prescription. Psychological Medicine 12, 201–206.CrossRefGoogle ScholarPubMed
Young, J. P. R., Hughes, W. C. & Lader, M. H. (1976). A controlled comparison of flupenthixol and amitriptyline in depressed out-patients. British Medical Journal i, 1116–1118.CrossRefGoogle Scholar
Zimmermann, H. & Rahlfs, W. (1980). Model building and testing for the change-over design. Biometrical Journal 22, 197–210.CrossRefGoogle Scholar